Table 1 Sub-group analysis for patients with superficial or complete wound dehiscence
Type of wound dehiscence | ||||
|---|---|---|---|---|
Superficial dehiscence (n = 45) | Complete dehiscence (n = 9) | p-value | ||
Age | 53.80 ± 11.14 | 59.11 ± 4.31 | p = 0.269 | |
BMI | 30.08 ± 4.89 | 32.04 ± 6.48 | p = 0.470 | |
Years of dialysis | 5.04 ± 3.73 | 4.50 ± 3.64 | p = 0.798 | |
Glucose (mmol/L) | 6.40 ± 1.91 | 6.58 ± 3.15 | p = 0.588 | |
Duration of NPWT (days) | 40.50 ± 25.80 | 58.40 ± 36.90 | p = 0.244 | |
Time to healing (days) | 45.69 ± 32.12 | 37.40 ± 25.81 | p = 0.882 | |
BMI | Quartile 1 | 9 (22.0%) | 0 (0%) | p = 0.266 |
Quartile 2 | 9 (22.0%) | 3 (42.9%) | ||
Quartile 3 | 10 (24.4%) | 3 (42.9%) | ||
Quartile 4 | 13 (31.7%) | 1 (14.3%) | ||
Sex | Male | 30 (66.7%) | 4 (44.4%) | p = 0.208 |
Female | 15 (33.3%) | 5 (55.6%) | ||
Type of dialysis | Predialysis | 2 (4.5%) | 1 (11.1%) | p = 0.238 |
Haemodialysis | 39 (88.6%) | 6 (66.7%) | ||
Peritoneal dialysis | 3 (6.8%) | 2 (22.2%) | ||
Smoker | 10/29 (34.5%) | 3/6 (50%) | p = 0.474 | |
Diabetes mellitus | 18/45 (40.0%) | 4/8 (50%) | p = 0.597 | |
Peripheral vascular disease | 5/45 (11.1%) | 4/9 (44.4%) | p = 0.014 | |
Type of donor | Living | 7 (15.6%) | 2 (22.2%) | p = 0.855 |
Brain death | 29 (64.4%) | 5 (55.6%) | ||
Cardiac death | 9 (20.0%) | 2 (22.2%) | ||
Immuno-suppression | Tacrolimusa | 35/45 (77.8%) | 6/8 (75%) | p = 0.863 |
Cyclosporinb | 10/55 (22.2%) | 2/8 (25%) | ||
Delayed graft function | 21/45 (46.7%) | 5/9 (55.6%) | p = 0.626 | |
Post-operative dialysis | 19/45 (42.2%) | 5/9 (55.6%) | p = 0.462 | |
Infection | 32/45 (71.1%) | 8/9 (88.9%) | p = 0.267 | |
Wound collection | 17/45 (37.8%) | 7/9 (77.8%) | p = 0.027 | |
Operative intervention | 3/45 (6.7%) | 9/9 (100%) | p < 0.001 | |
NPWT | 11/45 (24.4%) | 5/9 (55.6%) | p = 0.062 | |